Abstract
Podoplanin (PDP) is a mucin - a type of transmembrane protein expressed in numerous tissues during ontogeny and in adult animals, including the brain, heart, kidney, osteoblasts and lymphoid organs. The aim of this study was to determine podoplanin concentration in the blood serum and urine of patients with bladder cancer. Quantifying podoplanin concentration and its correlation with various clinicopathological parameters may be useful for more accurate predictions and identifying high-risk patients. The present study included 82 patients with bladder cancer confirmed by transurethral resection or cystectomy and 27 healthy volunteers. The Surface Plasmon Resonance Imaging biosensor was applied for the detection of podoplanin in the serum and urine samples. Significant differences in serum and urine podoplanin concentration levels were observed between bladder cancer patients. The statistically significant higher values of PDP were detected in serum of patients with invasive, more aggressive, larger, multifocal tumors. The association between podoplanin concentration and clinicopathological features indicates that it might be useful while making therapeutic decisions.
References
Nov 1, 1992·The Journal of Experimental Medicine·A G FarrA Aruffo
Feb 23, 1999·The American Journal of Pathology·S Breiteneder-GeleffD Kerjaschki
Nov 13, 2002·Annual Review of Physiology·Mary C Williams
Oct 30, 2004·International Journal of Cancer. Journal International Du Cancer·Ester Martín-VillarMiguel Quintanilla
Mar 4, 2005·The American Journal of Pathology·Vivien SchachtMichael Detmar
Apr 18, 2006·Cancer Cell·Andreas WickiGerhard Christofori
May 4, 2006·Advances in Anatomic Pathology·Nelson G Ordóñez
Jun 29, 2006·Cancer·Ping YuanLi Mao
Dec 21, 2006·British Journal of Cancer·A Wicki, G Christofori
Jul 10, 2007·The Journal of Biological Chemistry·Katsue Suzuki-InoueYukio Ozaki
Jun 10, 2008·Biochemical and Biophysical Research Communications·Naho AtsumiAtsushi Ochiai
Jul 29, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeo ItoAtsushi Ochiai
Feb 26, 2010·Cancer Science·Tibor SzarvasSüleyman Ergün
Jul 10, 2010·The American Journal of Pathology·Leah N CueniMichael Detmar
Aug 5, 2011·Current Opinion in Urology·Yuanbin RuDan Theodorescu
Dec 14, 2011·Nature Reviews. Urology·George J Netto
Apr 3, 2012·Journal of Clinical Laboratory Analysis·Karel KotaskaMarek Babjuk
Jun 15, 2012·Thrombosis Research·Kate L LoweStephen P Watson
Sep 19, 2012·Frontiers in Immunology·Jillian L AstaritaShannon J Turley
Mar 13, 2013·Molecular Diagnosis & Therapy·Steve GoodisonVirginia Urquidi
Nov 14, 2013·International Journal of Cancer. Journal International Du Cancer·Satoshi TakagiNaoya Fujita
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jun 3, 2014·BMC Cancer·Chun-Te WuMiao-Fen Chen
Aug 15, 2014·Oncology Letters·Ewa GorodkiewiczRobert Kozłowski
Citations
Oct 22, 2016·Analytical Biochemistry·A SankiewiczE Gorodkiewicz
Mar 31, 2017·Cellular and Molecular Bioengineering·Anna SankiewiczEwa Gorodkiewicz
Mar 14, 2018·Journal of Burn Care & Research : Official Publication of the American Burn Association·Ewa MatuszczakAdam Hermanowicz
Sep 25, 2017·Clinical and Experimental Immunology·E MatuszczakA Hermanowicz
Dec 22, 2017·Cancer Science·Xingpeng ZhaoYiming Zhao
Dec 19, 2018·Biosensors·Ewa Gorodkiewicz, Zenon Lukaszewski
Jan 4, 2020·Oncology Letters·Tomasz GuszczEwa Gorodkiewicz
Feb 10, 2019·International Journal of Molecular Sciences·Miguel QuintanillaEster Martín-Villar
Apr 3, 2020·Molecular Cancer Research : MCR·Axel JohnChristian Gorzelanny
Dec 12, 2020·Journal of Pharmaceutical and Biomedical Analysis·Pawel FalkowskiEwa Gorodkiewicz
Jan 14, 2021·Analytical Methods : Advancing Methods and Applications·Anna SankiewiczEwa Gorodkiewicz
Jan 1, 2021·Cancer Management and Research·Xinyi ZhuYiming Zhao
Jul 24, 2021·Journal of Proteomics·Rubén López-CortésCristina Núñez
Jan 19, 2021·ACS Biomaterials Science & Engineering·Sopan N Nangare, Pravin O Patil
Jul 20, 2017·ACS Sensors·Jean-Francois Masson